The EUVATION podcast is a constantly evolving platform where listeners can get inside knowledge on a host of technology related projects which are, in most cases, EU funded. From medicine, to self driving automobiles, nothing is off limits. Join us for some one-on- one time with the project partners responsible for getting the job done. We explore not only what they are doing but why.
In this episode, we talk about the iPC project with Matteo Manica. He's a research staff member at the IBM Research Lab in Europe at the Zurich location. He describes his role and some of the overarching goals of this four year project. From tumour and drug modeling efforts to artificial intelligence, iPC aims to reduce suffering and maintain a high quality of life for children suffering with cancer.
In this episode, we talk about the iPC project with project partner Pavel Sumazin from Baylor College of Medicine in the USA. He describes his role and some of the overarching goals of this four year project. From tumour and drug modeling efforts to making sense of multi-disciplinary data, iPC is poised to reduce human suffering and preserve a high quality of life for children suffering with cancer.
In this episode, we talk to María Rodríguez Martínez about the completion of the PrECISE project. A team of doctors and scientists recently finished a project aimed at collecting data from multiple sources and then using it to inform clinicians about the best treatment options for their patients suffering with prostate cancer. Project partners from Austria, Switzerland, Hungary, Germany, France and the USA worked in a highly specialised, EU funded consortium which took three years to complete. Learn more about the project and some of the outcomes right here.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668858.
This work was supported (in part) by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0324-2. The opinions expressed and arguments employed therein do not necessarily reflect the official views of the Swiss Government.